Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression
International Journal of Molecular Sciences · 01.07.2025 · 26 (13) · 6353
DOI: 10.3390/ijms26136353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.07.2025. Verfasst von Lucia Giordanengo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Translational Oncology Laboratory "Paola Gilardi", San Luigi Gonzaga University Hospital, University of Turin, 10043 Orbassan…. Hauptthemen laut MEDLINE: Neoplasms, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca e Progetto, Ricerca Locale 2023, University of Turin.
Abstract (Originalsprache)
Endothelial-to-mesenchymal transition (EndMT) is a dynamic cellular process characterized by a phenotypic-functional switch of cells from endothelial-to-mesenchymal traits. Many studies have identified EndMT as a key driver of tumor growth and progression. EndMT supports tumor cell proliferation by creating a tumor microenvironment that facilitates cancer cell survival. Notably, EndMT is an important source of cancer-associated fibroblasts, leads to immune dysregulation and immune escape, and supports metastasis and resistance to therapy. Hence, understanding the intricate relationship between EndMT and cancer progression offers exciting new avenues for therapeutic intervention. This review aims to describe the central role of EndMT in tumor progression, highlighting the molecular mechanisms underlying this endothelial alteration and its significant involvement at all stages of tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Translational Oncology Laboratory "Paola Gilardi", San Luigi Gonzaga University Hospital, University of Turin, 10043 Orbassano, Italy.
- Candiolo Cancer Institute-IRCCS-FPO, 10060 Candiolo, Italy.
- Molecular Biotechnology Center "Guido Tarone", University of Turin, 10126 Turin, Italy.
- Division of Medical Oncology, San Luigi Gonzaga University Hospital, 10043 Orbassano, Italy.
ORCID-Profile: Alessia Proment, Virginia Botta, Martina Olivero, Francesca Bersani, Dario Sangiolo, Giorgio Vittorio Scagliotti, Gabriella Doronzo
Förderung
- Ricerca e Progetto
- Ricerca Locale 2023
- University of Turin
Zitieren
APA
Giordanengo, L., Proment, A., Botta, V., Picca, F., Munir, H. M. W., Tao, J., Olivero, M., Taulli, R., Bersani, F., Sangiolo, D., Novello, S., Scagliotti, G. V., Merlini, A., & Doronzo, G. (2025). Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression. International Journal of Molecular Sciences, 26(13), 6353. https://doi.org/10.3390/ijms26136353
Vancouver
Giordanengo L, Proment A, Botta V, Picca F, Munir HMW, Tao J, et al. Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression. International Journal of Molecular Sciences. 2025;26(13):6353. doi:10.3390/ijms26136353
BibTeX
@article{Giordanengo2025,
author = {Giordanengo, Lucia and Proment, Alessia and Botta, Virginia and Picca, Francesca and Munir, H M Waqas and Tao, Jiahao and Olivero, Martina and Taulli, Riccardo and Bersani, Francesca and Sangiolo, Dario and Novello, Silvia and Scagliotti, Giorgio Vittorio and Merlini, Alessandra and Doronzo, Gabriella},
title = {Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6353},
doi = {10.3390/ijms26136353}
}
EUVIMED